Residual Embolism Evaluated With Single Photon Emission Computed Tomography
Condition(s) studied
Study summary
Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary vascular obstruction (RPVO) which can be assessed by pulmonary scintigraphy.
Eligibility
Primary outcome measure(s)
- RPVO (%) — At inclusion
Evaluation of the RPVO establish with Meyer score (planar scintigraphy, 2D). The higher the percentage, the greater the obstruction of the lung - Segmental visual score — At inclusion
Evaluation of segmental visual score (SPECT-CT , 3D) The higher the percentage, the greater the obstruction of the lung
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier Universitaire | Saint-Etienne | France | Recruiting |
More Centre Hospitalier Universitaire de Saint Etienne trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06473610 on ClinicalTrials.gov ↗ ← All trials in France